NCT07277413 A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT05975073 A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT04794699 Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion Status ACTIVE_NOT_RECRUITING Phase PHASE1